December 27, 2024 01:00 ET | Source: argenx SE VYVDURA® now approved for at-home self-injection in Japan for both generalized…
BOSTON, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company focused on transforming the…
Dubai, UAE, Dec. 20, 2024 (GLOBE NEWSWIRE) -- LCT (CoinW), a pioneering fintech company based in Dubai, proudly announces its…
WALTHAM, Mass., Dec. 13, 2024 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), today announced that the U.S. Food…
WALTHAM, Mass., Dec. 13, 2024 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), today announced that the U.S. Food…
WALTHAM, Mass., Dec. 13, 2024 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), today announced that the U.S. Food…
December 03, 2024 16:05 ET | Source: Beyond Air™ The Phase 1b study will evaluate LV UNO in unresectable cutaneous…
ZAVENTEM, Belgium, Nov. 11, 2024 (GLOBE NEWSWIRE) -- SYNDEO Medical, a Belgium-based leader in diagnostic and interventional procedural solutions, announces…